Canara Robeco Asset Management Co. Ltd. · NSE:CRAMC

Canara Robeco Asset Management — Investor Presentation (July 2024)

60 slides from Canara Robeco Asset Management's investor presentation, Jul 12, 2024

  1. Slide 1: Balanced Advantage Fund NFO

    NFO Opens: July 12, 2024 NFO Closes : July 26, 2024 This product is suitable for investors who are seeking* + Long term jpreciation with income generation + Investment in a dynamically managed portfolio of equity & equity related instruments and debt & money BALANCED ADVANTAGE FUND (Balanced Advanta

  2. Slide 2: Index

    CANARA ROBECO Mutual Fund INDEX WHY BALANCED ADVANTAGE FUND INTRODUCING CANARA ROBECO BALANCED ADVANTAGE FUND FUND INFORMATION, PRODUCT LABEL & DISCLAIMER

  3. Slide 3: Market Volatility & Investor Behaviour

    CANARA ROBECO Mutual Fund MARKET VOLATILITY & INVESTOR BEHAVIOUR

  4. Slide 4:   ƒ ‚ € ­      ƒ € „

      ƒ ‚ € ­      ƒ € „    ‚  ƒ  € ­ „   ‚     

  5. Slide 5:    ƒ ‚ € ­      ƒ €

       ƒ ‚ € ­      ƒ € „    ‚  ƒ  € ­ „   ‚     

  6. Slide 6: Numerous event risks lead to volatility in Equity Markets

    Numerous event risks with varying intensities leads to volatility in Equity Markets CANARA ROBECO Mutual Fund BSE Sensex Performance with key events 80,000 70,000 60,000 40,000 BSE SENSEX 30,000 - ore Crisis starts Lehman Bros file for bankruptcy Fed hikes rates first time innine yeaks Eurozone Debt

  7. Slide 7:  …  ­   €‚ ƒ      

     …  ­   €‚ ƒ           

  8. Slide 8: Behavioural Gap lowers investor returns

    CANARA ROBECO Mutual Fund ...resulting in relatively Lower Investor Returns a ~ Behavioural Gap Investment Returns Investor Returns SOURCE: INTERNAL ASSESSMENT

  9. Slide 9: † ‡ˆ ­Š”  ‰Š –“Š” š“Š” Ž ‘ ’ “‰‰” “› •“Š” 

    † ‡ˆ ­Š”  ‰Š –“Š” š“Š” Ž ‘ ’ “‰‰” “› •“Š”  ‰Š ˆ‹  ‘ ’Š“•–” ™“Š” Œ“Š” — ‘ œ ’ “ŒŠ” ­“Š” ˜“Š” ‰“Š” “Š” œ ГД ŒŠŠ ˆ    †‡‡ˆ‰†‡Šˆ

  10. Slide 10:  ‘ ‘žžŸ ‘‘ ‰ŠŠ   ƒ  € ‡ ‘‘ ¡ ¢“

     ‘ ‘žžŸ ‘‘ ‰ŠŠ   ƒ  € ‡ ‘‘ ¡ ¢“ ƒ ‰ŠŠ ˜ˆ  €    ’  ’   “’ƒ “’€ “’„ “’ “’ “’ “’‚ “’ “’ƒ “’ “’€ “’­ “’„ “’ “’ “’‚ “’ “’ “’ ”•–—˜Ž”•“™ š›œž˜ ™ ‹ ŒŽ ‘ Ž Œ‘ 

  11. Slide 11: ‰ŠŠ–‰Š Š£„‘ŽŽ ‰Š‰Š‰Š‰Š£Ž Ž ƒ£ £ ”Ÿ   ƒ ”Ÿ € ­ 

    ‰ŠŠ–‰Š Š£„‘ŽŽ ‰Š‰Š‰Š‰Š£Ž Ž ƒ£ £ ”Ÿ   ƒ ”Ÿ € ­   €  ­„ ­   ‡ ‘‘ ¡ ¢“ ‡ ‘‘ ¡ ¢“ ­ ­‚  ‰ŠŠ ‰ŠŠ  ­­  ­ ­ ƒ ’­ ­ € ­ „ ’   ’­ ‚  ­ ’­ ¤Ÿ¥”“Ÿ›”•–— ’­   ’

  12. Slide 12: MF Net Flows vs BSE200 P/E

     ‘ ‘‘ ‰ŠŠ   ­ ƒ  € ‡ ‘‘ ¡ ¢“ ­  ‰ŠŠ¤˜ˆ   0 ­ ’ ’   “’ƒ “’€ “’„ “’ “’ “’ “’‚ “’ “’ƒ “’ “’€ “’­ “’„ “’ “’ “’‚ “’ “’ MF Net Flows (Qtrly) “’ BSE200 P/E 3m Avg (RHS)   ­€‚ €ƒ „  †‡ ˆ  † ‰Š

  13. Slide 13: ‘   ž šž‰Š£˜“ ”Žˆ„ ¥ Œ¥ ™£Š” ¤Ÿ¥”“Ÿ›”•–— ­ € ƒ ¤Ÿ¥”“Ÿ›”•–—

    ‘   ž šž‰Š£˜“ ”Žˆ„ ¥ Œ¥ ™£Š” ¤Ÿ¥”“Ÿ›”•–— ­ € ƒ ¤Ÿ¥”“Ÿ›”•–— ­   €  ‡ ‘‘ ¡ ¢“ ‡ ‘‘ ¡ ¢“ ­  ‰ŠŠ¤˜ˆ ‰ŠŠ¤˜ˆ ¥–š œž ­ƒ  ­ ¥–š œž €    „   ­ ƒ   ‚  ƒ ­ ”–¥¢•œž ‚‚ ”–¥¢•œž „ ‚ € 

  14. Slide 14: Why Balanced Advantage Fund

    \utual Fund WHY BALANCED ADVANTAGE FUND

  15. Slide 15: ˆ ‘ ¦ ˆŽˆž ˆˆ„ ž‚ ›   ­ › ˆ ¥¦ ¦

    ˆ ‘ ¦ ˆŽˆž ˆˆ„ ž‚ ›   ­ › ˆ ¥¦ ¦ ž§ ‘

  16. Slide 16: Ÿ Ÿ   ˆ Ž ‘ ¨ £  ‚£ ­£ £ €£

    Ÿ Ÿ   ˆ Ž ‘ ¨ £  ‚£ ­£ £ €£ £ ƒ£ ‚€£  ƒ£ £ ­£ £ ­£ €£  £ £ ƒ£ £ ‚£ €£ ­£ £ £ ¤Ÿ¥”“ ¥š¢–› „­§­ ‚§ ­§­ §‚ ”Ÿ ”ššœ¥”¥– œž”Ÿ ”ššœ¥”¥–   Ž‘‘— Ž‘Ž˜  „ „™ ™™Š„”‚ „  †‡ ˆ  † ‰Š   

  17. Slide 17: ˆ ‘ © ª   ‰Š ˜ ‰Š ­ ‰Š Œ ‰Š ™

    ˆ ‘ © ª   ‰Š ˜ ‰Š ­ ‰Š Œ ‰Š ™ ‰Š • ‰Š š ‰Š – ‰Š‰Š ‰Š‰ ‰Š‰‰ ‰Š‰˜ Ž« ™ €‚ „ „ €‚ „ „ €‚ €‚ €‚ €‚ €‚ œ žŸ¡ ’œ˜—¡ Ÿ ž’¡ ”Ž •”¡ ’— ‘Ÿ¡ — •”¡ ”‘ œŽ¡ ”œ Ÿœ¡ Ž• ””¡ — ž•¡ Ž˜ —ž¡ Ÿ œ”¡ €‚ ™ ™ ™ ™ ™ €‚ ™ ™ ™ ™ ™ ž ‘ž¡ ’˜ —’¡ ’ ——¡ — ˜•¡ Ž‘ ”ž¡ ” ””¡ ”‘ ’œ¡ ”’ ˜‘¡ ”’ ŸŸ¡ ’ Ÿ”¡ ”Ÿ žŽ¡ ž ž

  18. Slide 18: Key Features of Balanced Advantage Fund

    Key Features of Balanced Advantage Fund Balanced Advantage Fund CANARA ROBECO Mutual Fund Eliminate investor behavior bias Model based asset allocation Dynamic rebalancing of portfolio Actively managed Debt & Equity portfolio Disciplined approach Tax-efficient returns

  19. Slide 19: Introducing Canara Robeco Balanced Advantage Fund

    CANARA ROBECO Mutual Fund jut: INTRODUCING CANARA ROBECO BALANCED ADVANTAGE FUND

  20. Slide 20: Žˆ‘ ˆ  ˆ €‚ ƒ„„ ƒ„† œ Ž œ œ  † 

    Žˆ‘ ˆ  ˆ €‚ ƒ„„ ƒ„† œ Ž œ œ  †  ¢

  21. Slide 21: ¦  ˆ„ ˆ  ¤ ­  €  ‚ƒ  „ ­

    ¦  ˆ„ ˆ  ¤ ­  €  ‚ƒ  „ ­ „ † ‡ ˆ ◦ ‚ “ƒ ˆ ‡ ‚ ◦ ‚‡“ƒ ˆ † §¬‘ˆŽž ◦ ˆ„ ‚ “ ‰‡ˆŠ ž † ­ ‰ †† †„ † † ‹ ‡ ‘ž‚ˆ ‡¦«› ¤ ¦ ­ ◦ ˆ † † ‚Œ ◦ ‡ †† ‚    ‰Š™ ‰   †  Œ  ¢ ˆ ¢

  22. Slide 22:  €  Š™ Ž ˆ€ † ‡ € €‡ ‚ ‡ˆ † †

     €  Š™ Ž ˆ€ † ‡ € €‡ ‚ ‡ˆ † † † † ‡ ‡ †‡ † € € † Š ‘ ‡ˆ„ ’‡ † † ˆ ‚

  23. Slide 23: CR BAF Model Portfolio vs Benchmark Index

     ‰Š ˆ §žŽˆˆˆžŽˆž£~žˆ ˆ©™•” 1600 100.0% 1400 1200 75.0% 1000 800 600 50.0% 400 200 0 25.0% CR BAF Model Portfolio Benchmark Index* Avg. Mthly Equity Allocation (RHS)   £ƒŒ ”‘‘  ˆ‡¤‰Œ —‘—‘ ‡ „  † ˆ “ ˆ ™  ™  ¢ ˆ

  24. Slide 24: P/B and model portfolio equity allocation

     ‰Š ˆ ‰ §  8 90% 7 85% 80% 6 75% 5 70% 4 65% 3 60% 55% 2 50% 1 45% 0 40% May-04 May-05 May-06 May-07 May-08 May-09 May-10 May-11 May-12 May-13 May-14 May-15 May-16 May-17 May-18 May-19 May-20 May-21 May-22 May-23 May-24 P/B (LHS) CR BAF Model Portfolio   †ˆ£€Ž‘‘ „  † ˆ ˆ ™  ™ 

  25. Slide 25: Forward P/E and model portfolio equity allocation

     ‰Š ˆ ‰‘  § ‘  25 90% 85% 20 80% 75% 15 70% 65% 10 60% 55% 5 50% 45% 0 40% Nov-05 Feb-05 Aug-06 Nov-08 Feb-08 Aug-09 Nov-11 Feb-11 Aug-12 Nov-14 Feb-14 Aug-15 Nov-17 Feb-17 Aug-18 Nov-20 Feb-20 May-04 Aug-21 Nov-23 Feb-23 May-07 May-10 May-13 May-16 May-19 May-22 Forward P/E (LHS) CR BAF Mod

  26. Slide 26: Equity Risk Premium and model portfolio allocation

     ‰Š ˆ   §   4 90% 3 85% 2 80% 1 75% 0 70% -1 65% -2 -3 60% -4 55% -5 50% -6 45% -7 40% May-04 May-05 May-06 May-07 May-08 May-09 May-10 May-11 May-12 May-13 May-14 May-15 May-16 May-17 May-18 May-19 May-20 May-21 May-22 May-23 May-24 Equity Risk Premium (LHS) CR BAF Model Portfolio   €‚Š

  27. Slide 27: Model portfolio returns vs benchmark index

    § ® ž Žˆ‘  ¡ ‰š‰Š‰­¢ CR BAF Model Portfolio Benchmark Index 25% 23.2% 20% 19.2% 15% 14.1% 14.1% 13.5% 12.9% 12.9% 12.7% 12.4% 11.4% 11.9% 12.3% 11.1% 11.2% 10% 5% 0% 6 Months 1 Year 3 Years 5 Years 10 Years 15 Years 20 Years Ÿ”¡¨–›¢ ‚£ ££££„£€£  ˆ‡¤‰Œ —‘—‘ ‡ ƒ”𤙠‹ ”𤉙›ŠŠ

  28. Slide 28: ©Ž ® ‰ŠŠ Ž « Žˆ‘ ‰ŠŠ ¦  Ž‘”Ž Žœ ’¡ ’’ Ž¡

    ©Ž ® ‰ŠŠ Ž « Žˆ‘ ‰ŠŠ ¦  Ž‘”Ž Žœ ’¡ ’’ Ž¡ ŸŽ¡ Ž‘”’ — œ¡ ž ”¡ •’¡ Ž‘”˜ ’‘ Ž¡ ’œ˜¡ Ÿ”¡ Ž‘”— ’ ž¡ “‘ Ž¡ Ž‘”ž Ÿ ”¡ — ˜¡ Ž‘”œ Ž˜ ‘¡ ’— ‘¡ ž•¡ Ž‘”Ÿ Ž Ÿ¡ ‘ Ÿ¡ Ž‘”• ”” ž¡ ”‘ ˜¡ ޑޑ ”— Ÿ¡ ”œ •¡ ŸŸ¡ ޑޔ ”• ”¡ Ž• ”¡ žž¡ Ž‘ŽŽ — •¡ — œ¡ ޑޒ ”Ÿ ‘¡ Ž˜ —¡ œ’¡ „  † ˆ ˆ ™  ¢  

  29. Slide 29: CAGR returns, standard deviation and Sharpe ratio

      ® ‰ŠŠ  ¨ 40% 35.3% 35% 31.3% 30% 26.1% 25% 20% 17.5% 15.3% 15% 13.3% 10% 5% 0% CAGR Returns Standard Deviation Sharpe Ratio Model BSE200 TRI   š™” ‰ŠŠ ™•” ‰ŠŠ ’”“ “‘—ŽŸ“ “Ž˜ ”š›“šŠˆ“Š Š „  † ˆ ˆ ™  ¢   `

  30. Slide 30: Canara Robeco BAF is based on a Total Return approach

    CANARA ROBECO Mutual Fund Canara Robeco BAF is based on a Total Return approach a A dynamic asset allocation to suit investors’ risk tolerance Aims to deliver returns with a combination of Base Return and Capital Gains Base Return + Capital Gains Investors’ Risk Tolerance Dynamic Asset Allocation No

  31. Slide 31: Ž ˆ ‘ „ž‡¦«£™Œ” ŠŠ” ž ŽˆˆŽ «ˆŽ ˆ ‡¦«£˜Š”–Š” žˆ ž‘žžˆ„« ¬ˆˆŽ„ ˆžŽˆž±

    Ž ˆ ‘ „ž‡¦«£™Œ” ŠŠ” ž ŽˆˆŽ «ˆŽ ˆ ‡¦«£˜Š”–Š” žˆ ž‘žžˆ„« ¬ˆˆŽ„ ˆžŽˆž±  £Š”˜Œ” ŽˆˆˆžŽž ˆˆŽ ˆ —ˆˆ„ ‘¦ ˆŽ›„ž‘ž Žžˆžž‘‘¦ ˆˆ„† ˆŽ— ž ˆˆ ˆŽ› ž—‰Š«ˆž °‡¦ˆˆ—ˆˆ« ˆˆ„ ˆŽžˆ›Ž«Ž „ ‚„ ™™  ¢

  32. Slide 32: Why Canara Robeco Balanced Advantage Fund

    \utual Fund WHY CANARA ROBECO BALANCED ADVANTAGE FUND

  33. Slide 33: Ÿ¦   … § ‰Š« Š« 100% 100%  80%  80% ®

    Ÿ¦   … § ‰Š« Š« 100% 100%  80%  80% ® ® 60% 60% ƒ£ ‰ŠŠ ™‰” ‰ŠŠ Œ–” 40% 81% 40% 84% 20% 20% 0% 0% ­„£ -20% -20% ¦ ¦ -62% -59% -40% -40%   ® -60% ® -60% ‰ŠŠ š˜” -80%  šŠ” -80% -100% -100% –𕠐 –𕠐 „  † ˆ ˆ ™  ™  ¢ ˆ  

  34. Slide 34: … ˆ —  ‰ŠŠ ‰ŠŠ «¯‰ŠŠ «¯Žˆ‘ ¦ ¤ ˆ” ¡ ˆ¢ ¡

    … ˆ —  ‰ŠŠ ‰ŠŠ «¯‰ŠŠ «¯Žˆ‘ ¦ ¤ ˆ” ¡ ˆ¢ ¡ ˆ¢   Ž “”€€”• ž™‹“Ÿ ž‹™ 𔋔 ––‹˜•Ÿ –“‹š–Ÿ  “–€— €”• ˜”‹•Ÿ “‹• –•‹› ›”‹žžŸ “›‹œ•Ÿ  “–€ €”˜ ž›‹”Ÿ •‹™ š™‹œ €››‹™œŸ €“˜‹žœŸ  “–€€”™ ™ž‹–Ÿ š‹• ––‹• ˜“‹›žŸ ›•‹œ–Ÿ  “–€€–” •“‹˜Ÿ “‹• šš‹™ €–“‹˜–Ÿ €˜‹˜–Ÿ  “–€€–– ˜ž‹“Ÿ š‹• –›‹“ ˜‹“–Ÿ ™‹˜“Ÿ  š™

  35. Slide 35: … ¡ “¢ £ ‰ŠŠ•ž‰Š Š ‰£‰Š Š ‰Š ­    £

    … ¡ “¢ £ ‰ŠŠ•ž‰Š Š ‰£‰Š Š ‰Š ­    £ Œ“•”  £‰š“ ” ‰ŠŠ£‰“˜” ‰ŠŠ£‰˜“–”     ’¦š”– Re-¦š”– „   ‚ „ ­ ƒ  ‚ Ÿž’ƒ ¢’ƒ Ÿž’„ ¢’„ ¢”’ƒ ¦’ƒ ¢”’„ ¦’„ ¡’ƒ ‹Ÿ’ƒ ¡’„ ‹Ÿ’„ ¢’‚ Ÿž’ ¢”’ ¦’ Ÿž’ ¡’ ‹Ÿ’ Ÿž’ ¦’ –œ’ –œ’ ¦’ –œ’ “’ “’ Ÿž’

  36. Slide 36: … ¡ “¢ ˜£‰Š Œ‰Š ™ ­£ž‰Š‰ ‰Š‰‰    £–“𔠁 £˜“˜”

    … ¡ “¢ ˜£‰Š Œ‰Š ™ ­£ž‰Š‰ ‰Š‰‰    £–“𔠁 £˜“˜” ‰ŠŠ£­“Œ” ‰ŠŠ£Š“Œ”  ­ ­  ’¦š”– Re-¦š”–  „­ „­ „ „ ƒ­ ƒ­ ƒ ƒ ¡’€ ¡’­ Ÿž’€ Ÿž’­ ¢’­ ‹’€ ¦’€ ¢”’­ –œ’­ ¡’€ ¡’­ ‹Ÿ•’€ ‹Ÿ•’­ ‹Ÿ’€ ‹Ÿ’­ “’€ “’­ ’€ ’­ ¡’ Ÿž’ ¢’ ‹’ ¢”’ ¦’ ‹Ÿ•’ ¡’ –œ’ ‹Ÿ’ “’

  37. Slide 37: Žˆ‘ £  ‰ŠŠ£ £ €£ £ -£ -£ -£ ’£ -€ £ -‚„£

    Žˆ‘ £  ‰ŠŠ£ £ €£ £ -£ -£ -£ ’£ -€ £ -‚„£ ’£ -‚­£ ’£ -€£ -ƒƒ£ ’ £ -‚­£ - £ ’­£ ’€£ -­­„£ ¢’ƒ ’„ ¢’ ’ ¢’­ ’€ –š•–”¨–•¥–   ‚ „  † ˆ ˆ ™  ¢  

  38. Slide 38: Žˆ‘ £  ‰ŠŠ£Š”š” „£ ƒ‚£ ‚„£ ƒ£ ‚£ €£ ­ £ ƒ£ ƒ£

    Žˆ‘ £  ‰ŠŠ£Š”š” „£ ƒ‚£ ‚„£ ƒ£ ‚£ €£ ­ £ ƒ£ ƒ£ ­£  £  £ ­£ £ ƒ£ £ „£ £ ‚£ €£ ƒ£ £ £ ­£ £ £ ‹Ÿ’ ¡’ ¡’­ ‹Ÿ’€ ¢’ƒ ¡’„ ¡’ ¡’ –š•–”¨–•¥–   ‚ „  † ˆ ˆ ™  ¢  

  39. Slide 39: Žˆ‘ £  ‰ŠŠ£š” Œ”  £ ƒ£ ­£ ­£ ƒ£ £ £ €£

    Žˆ‘ £  ‰ŠŠ£š” Œ”  £ ƒ£ ­£ ­£ ƒ£ £ £ €£ £ ƒ£  £  £ „„£ „„£ £ „€£ ƒ„£ ƒƒ£ ƒ£ ƒ£ €£ £ £ £ ’‚ ‹Ÿ’„ ’ ‹Ÿ’ ¡’€ ’ƒ ‹Ÿ’„ ¢’„ –š•–”¨–•¥–   ‚ „  † ˆ ˆ ™  ¢  

  40. Slide 40: Žˆ‘ £  ‰ŠŠ£² Œ” ­£ £ £ ­£ ƒ£ 29.1% £ €ƒ£ ­£

    Žˆ‘ £  ‰ŠŠ£² Œ” ­£ £ £ ­£ ƒ£ 29.1% £ €ƒ£ ­£ ­£  £ £ ƒ£ £ „£ „€£ £ ‚„£ ƒƒ£ 15.7% ‚£ ­£ ­ƒ£ ­£   £ £ ­£ £ ¢’ ¢’­ ¢’€ ’ƒ ‹Ÿ’ ’ ‹Ÿ’‚ ¢’ ‹Ÿ’ –š•–”¨–•¥–   ‚ „  † ˆ ˆ ™  ¢  

  41. Slide 41: ˆ   £ ¤ ˆ •Š”£˜Š”œ  ‘Ž ¯¤ Š” ± „ 

    ˆ   £ ¤ ˆ •Š”£˜Š”œ  ‘Ž ¯¤ Š” ± „   †  Œ  ¢ ˆ ‚„ ™™– ˆ

  42. Slide 42: ‘ ˆ   §‡   ‡† † ‡ ¡ „ „ „

    ‘ ˆ   §‡   ‡† † ‡ ¡ „ „ „ ˆ ‡ † ‡ †€ ‚ ˆ„ ‚† ˆ ¡ €† „   †  Œ  ¢ ˆ ‚„ ™™–

  43. Slide 43: Ž ˆ ‘ © › ˆ £ Š † ¢ † ‡ € †

    Ž ˆ ‘ © › ˆ £ Š † ¢ † ‡ € † £ ¢ ‡ ‡ ‚€ 𔀠 ‚ †¤¥Œ Š ‚ƒ ¤Š¥ „ ‚ ¤¥ ¦ † ˆ‚Œ‡ ‚€† Š  ‡‚€ ‘ €§€ „ †¤Šš””¥  † „ •›Ÿ ‡† ˆ‡ „ ‚„ ™™– ¢

  44. Slide 44: ‚§ž§ž¦ —§‘¦ ³ ­ ‹ € ‚ ƒ ­  ¢ ¢ ˆˆ 

    ‚§ž§ž¦ —§‘¦ ³ ­ ‹ € ‚ ƒ ­  ¢ ¢ ˆˆ 

  45. Slide 45: ˆ¦ž‚Ž§‘ˆŽ«   ™  „ „ ¥ € ‡ ‡ Œ š‡ Žž

    ˆ¦ž‚Ž§‘ˆŽ«   ™  „ „ ¥ € ‡ ‡ Œ š‡ Žž Ž‘Ž˜  ‰  ¨ ˆ ˆ‡ˆ ‚‚ š•— š”šž ‹  ¢™ ƒ ‡€‡ƒ

  46. Slide 46: ˆ ˆžžž—ˆˆ„„ ˆ §ˆŽ¦Ž¦ ˜‚ ” Ž ’ ˜  ‰Š ‰Š ‰Š ‰Š

    ˆ ˆžžž—ˆˆ„„ ˆ §ˆŽ¦Ž¦ ˜‚ ” Ž ’ ˜  ‰Š ‰Š ‰Š ‰Š ^ ƒ‚ ¦“   ¢™ ƒ ‡€‡ƒ ^„

  47. Slide 47: ˆ ˆžžž—ˆˆ„„ ˆ ˆ ˆ ‡ š›Ÿ † †„ ˆ ‡ †† –” ‰Š

    ˆ ˆžžž—ˆˆ„„ ˆ ˆ ˆ ‡ š›Ÿ † †„ ˆ ‡ †† –” ‰Š Œˆ  € ‡

  48. Slide 48: ‘¦ ‘ˆ¦   ˆ ‘ ˆž ˆ ˆ‘     ­€‚

    ‘¦ ‘ˆ¦   ˆ ‘ ˆž ˆ ˆ‘     ­€‚ “§œ ¨ ‹ “ †‚‚ƒƒ‚  ˆ  ŠŒƒ ‹ ‚ ‰ˆ‚ƒ ‚‚ Ž‚ ƒƒ‚„  ™Œ ŠŠ — § Š ˜Œ   ¡¢„ ƒ ‚ ¡¢ Ž‚ £  Ž‚  Ž‚ †‡ˆ  œ‘ œ ˆ› £ £ †ˆ  ˆ ” ¤ ‰” ˜™Œ  ¤ ‰” ˜™Œ  ¤ ˜™Œ ˆ‰Š ‚ˆ ‚ˆ‹ Ž§ ŒŠ¯ŒŠ© ¦  ‚„ ™™

  49. Slide 49: ‘¦ ˆˆ„¡¦ ¢ † „ ‡ ˆ ▪  ‰Ž„‹Œ ▪  ‰Š„‹Œ ▪

    ‘¦ ˆˆ„¡¦ ¢ † „ ‡ ˆ ▪  ‰Ž„‹Œ ▪  ‰Š„‹Œ ▪  ‘’„‹Œ ▪  ‰’„‹Œ ▪  Œ¤€‚ ▪  ‡ ▪ ™ © ¤ ‰Š ™ ‰ “ ▪ € ¤€‚ ˆ ‰ €‚‰Š ™  Œ ‰ ‰Š ™ Š Ž‘”ž  Š ™ ‰  ‰  ™ ‰   ¥ ”••œ  ¢ Ž‘”Ÿ ‰Š  ޑޔ  ›„ Š™ ¢‰Š  ▪ €‡ ‚  „ ▪ ™ ˆ‚  ˆ ¥ „ Œ‰ – ˆ ™ ƒ ‡ Ž— Œ ™ ƒ › ‰ ƒ ‡ ™ˆŠ€‚ƒ ▪ ™‰Š ™ ‰ ▪ ™‰Š ™ ‚ˆ

  50. Slide 50: About Canara Robeco

    \utual Fund ABOUT CANARA ROBECO

  51. Slide 51: §ŽˆˆˆžŽž° ‚  ¨ ˆ Ž Œ ± ž°Ž  “—“¡ ¢ ‹ ‰£‰Š

    §ŽˆˆˆžŽž° ‚  ¨ ˆ Ž Œ ± ž°Ž  “—“¡ ¢ ‹ ‰£‰Š  Ž‘‘œ

  52. Slide 52: ŽˆˆˆžŽž—§žž§«ž¥Ž— € “‚”€‚” ‚ € “•€ 

    ŽˆˆˆžŽž—§žž§«ž¥Ž— € “‚”€‚” ‚ € “•€ 

  53. Slide 53: ž¦—žŽ‡¦« Ž Š “ ˆƒ ‰Š    ‘ — ‹Š ­‰ “

    ž¦—žŽ‡¦« Ž Š “ ˆƒ ‰Š    ‘ — ‹Š ­‰ “  ƒ‚ ‰ƒ ­ ‹  ‹ ‰”  •€– ˆ‰ ˆ ¦ ‘ ‹ „Œ„ ŽŠ„„‘ „ ‹’‘   ‰Š™ ‰ 

  54. Slide 54: ž¦—žŽ   ‹ ˆ €  ‹ Ž ˆ œ œ  Ÿ

    ž¦—žŽ   ‹ ˆ €  ‹ Ž ˆ œ œ  Ÿ   œ   ‰Š™ ‰ 

  55. Slide 55: ž¦ žž„« Ž ¤  – „ — Ž ˜ ˆ„ — ™ „

    ž¦ žž„« Ž ¤  – „ — Ž ˜ ˆ„ — ™ „ – — Ž œ   ‰Š™ ‰  ¢

  56. Slide 56: Product suitability and scheme riskometer

    ž ¦Žˆ ŽˆˆˆžŽžˆˆŽ ˆ —ˆˆ„‘¦ ™“™ “„ ™™ This product is suitable for investors who are seeking* ħ 2¹´ŸÑˆÆ³iãÑi®iÃÃÆˆ£iÑ£¹´Þ£Ñ¢£´¹³ˆ Ÿˆ´ˆÆiÑ£¹´ ħ '´ÝˆÊѳˆ´Ñ£´i„à´i³£i®®à³i´iŸˆ„ùÆÑ‘¹®£¹ SCHEME RISKOMETER BENCHMARK RISKOMETER ¹‘ˆÅÔ£ÑàĸˆÅÔ£ÑàÆˆ®iш„£´ÊÑÆÔ³ˆ´ÑÊi´„„ˆ~Ñ Benchmark Riskometer i

  57. Slide 57: Annexure

    \utual Fund ANNEXURE

  58. Slide 58: ˆž¦ž¦ˆˆ„ š €›‚€‚— — ”­–˜€€€ œ“˜­‚ž  ‰‰Ÿ„ ‹€ ‰£‘£† £’„ Š‚ €† ™„

    ˆž¦ž¦ˆˆ„ š €›‚€‚— — ”­–˜€€€ œ“˜­‚ž  ‰‰Ÿ„ ‹€ ‰£‘£† £’„ Š‚ €† ™„ „ “ ‰Ž‰š ­ €  ‘¢‘¡ ` ‰’—¡’ “¡‰†‘¢‘Š –„ „ `‰¡—‰‘ “¡‰†‘¢‘Š  „¤ œˆ„¥‹ ž ¥ œ ˆ„¥ ž ­„

  59. Slide 59: Name of scheme: product labels and risk matrices

    NAME OF SCHEME Canara Robeco Ultra Short Term Fund Ultra Short Duration Fund - An open ended ultra-short term debt scheme investing in debt & money market instruments such that the Macaulay duration of the portfolio is between 3 months and 6 months. A relatively low interest rate risk and moderate c

  60. Slide 60: Name of scheme: product labels and risk matrices

    NAME OF SCHEME Canara Robeco Overnight Fund Overnight Fund - An open-ended debt scheme investing in overnight securities. A relatively low interest rate risk and relatively low credit risk. THIS PRODUCT IS SUITABLE FOR INVESTORS WHO ARE e Regular income over short term that may be in line with the o

Canara Robeco Asset Management — Investor Presentation (July 2024) on 6ix